Living donor liver transplantation for hepatitis B cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 12, 2007, Pages 2124-2129

  Karasu, Zeki ^a   Akyildiz, Murat ^a   Kilic, Murat ^a   Zeytunlu, Murat ^a   Aydin, Unal ^a   Tekin, Fatih ^a   Yilmaz, Funda ^a   Ozacar, Tijen ^a   Akarca, Ulus ^a   Ersoz, Galip ^a   Gunsar, Fulya ^a   Ilter, Tankut ^a   Lucey, Michael R ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Hepatitis B virus; Hyperimmune hepatitis B immunoglobulin; Lamivudine; Liver transplantation; Recurrence

Indexed keywords

ADEFOVIR; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HYPERIMMUNE GLOBULIN; LAMIVUDINE;

ADULT; ALLOGRAFT; ANTIGEN DETECTION; ARTICLE; CHEMOPROPHYLAXIS; CHRONIC HEPATITIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; SUPERINFECTION; SURVIVAL;

EID: 36348994223     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04782.x     Document Type: Article

References (26)

1. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 1993 329 : 1842 7.
2. Lok AS. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl. 2002 8 : S67 73.
3. Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology 2000 32 : 1189 95.
4. Marzano A, Salizzoni M, Debernardi-Venon W et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J. Hepatol. 2001 34 : 903 10.
5. Yao FY, Osorio RW, Roberts JP et al. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl. Surg. 1999 5 : 491 6.
6. Yoshida EM, Erb SR, Partovi N et al. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin. Liver Transpl. Surg. 1999 5 : 520 5.
7. Rosenau J, Bahr MJ, Tillmann HL et al. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J. Hepatol. 2001 34 : 895 902.
8. McCaughan GW, Spencer J, Koorey D et al. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. Liver Transpl. Surg. 1999 5 : 512 19.
9. Angus PW, McCaughan GW, Gane EJ, Crawford DH, Harley H. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against post-transplantation hepatitis B. Liver Transpl. 2000 6 : 429 33.
10. Sugawara Y, Makuuchi M, Imamura H et al. Living donor liver transplantation in adults - recent advances and results. Surgery 2002 132 : 348 52.
11. Trotter J, Wachs M, Everson G, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N. Engl. J. Med. 2002 346 : 1074 82.
12. Mistik R, Balik I. Turkiyede viral hepatitlerin epidemiyolojik analizi [Epidemiology of viral hepatitis in Turkey]. In : Tekeli E, Balik I, eds. Viral Hepatit 2003 [Viral Hepatitis 2003]. Ankara : Viral Hepatitle Savasim Dernegi, 2003 9 57 (in Turkish).
13. Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N. Engl. J. Med. 2004 351 : 2730 9.
14. Grellier L, Mutimer D, Ahmed M et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996 348 : 1212 15.
15. Anselmo DM, Ghobrial RM, Jung LC et al. New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann. Surg. 2002 235 : 611 19.
16. Seehofer D, Rayes N, Naumann U et al. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation 2001 72 : 1381 5.
17. Chu CJ, Fontana RJ, Moore C et al. Outcome of liver transplantation for hepatitis B: report of a single center's experience. Liver Transpl. 2001 7 : 724 31.
18. Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl. 2002 8 : 2 9.
19. Karasu Z, Ozacar T, Akyildiz M et al. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation. Antivir. Ther. 2004 9 : 921 7.
20. Dienstag JL, Perrillo RP, Schiff ER, Bartholomey M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 1995 333 : 1657 61.
21. Nevens F, Main J, Honkoop P et al. Lamivudine therapy for chronic hepatitis B: a 6-month randomized dose-ranging study. Gastroenterology 1997 113 : 1258 63.
22. Zeuzem S, de Man RA, Honkoop P, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J. Hepatol. 1997 27 : 431 6.
23. Allen MI, Deslauriers M, Andrews CW et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 1998 27 : 1670 7.
24. Benhamou Y, Katlama C, Lunel F et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann. Intern. Med. 1996 125 : 705 12.
25. Honkoop P, De Man RA, Niesters HGM et al. Quantitative hepatitis B virus DNA assessment by the limiting dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy. J. Viral Hepat. 1998 5 : 107 12.
26. Sugawara Y, Makuuchi M, Kaneko J, Akamatsu N, Imamura H, Kokudo N. Living donor liver transplantation for hepatitis B cirrhosis. Liver Transpl. 2003 9 : 1181 4.